Abstract

Rapid emergence of drug resistant Human Immunodeficiency virus (HIV) variants and severe side effects of anti-HIV drugs limit the efficacy of existing anti-HIV therapies. Efforts are being made to develop newer anti-HIV agents. Few newer anti-HIV agents reached the different clinical phases of development and appear promising for future therapy. The present article highlights the current status of available anti-HIV drugs, emerging anti-HIV drug agents and recent anti-HIV drugs patents information.

Keywords: AIDS, antiretroviral drugs, clinical studies, emerging drugs, HIV, patents, NRTIs, zidovudine, Rilpivirine, Apricitabine